Vitamin E inhibits CD95 ligand expression and protects T cells from activation-induced cell death

Journal of Clinical Investigation

Volumn 110, Issue 5, 2002, Pages 681-690

  Li Weber, Min ^a   Weigand, Markus A ^b   Giaisi, Marco ^a   Süss, Dorothee ^a   Treiber, Monika K ^a   Baumann, Sven ^a   Ritsou, Elena ^a   Breitkreutz, Raoul ^a   Krammer, Peter H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR AP 1;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN EXPRESSION; ARTICLE; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0036732036     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0215073     Document Type: Article

References (58)

1. CD95 (APO-1/Fas)-mediated apoptosis in normal and malignant liver, colon, and hematopoietic cells
2. Molecular cloning and expression of the Fas ligand, a novel member of the TNF family
3. Fas ligand-induced apoptosis as a mechanism of immune privilege
4. Fas ligand mediates activation-induced cell death in human T lymphocytes
5. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas
6. Autocrine T-cell suicide mediated by APO-1(Fas/CD95)
7. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation
8. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes
9. Programmed cell death as a mechanism of CD4 and CD8 T cell deletion in AIDS. Molecular control and effect of highly active anti-retroviral therapy
10. Mechanisms of HIV-associated lymphocyte apoptosis
11. Decreased antioxidant defence in individuals infected by the human immunodeficiency virus
12. Antioxidant status and lipid eroxidation in patients infected with HIV
13. The potential role of vitamin E in the treatment of immunological abnormalities during acquired immune deficiency syndrome
14. Vitamin E is an important factor in T cell differentiation in thymus of F344 rats
15. Association between serum vitamin A and E levels and HIV-1 disease progression
16. The role of metabolism in the antioxidant function of vitamin E
17. Vitamin E status and immune function
18. Vitamin and immunity
19. Vitamins and immunomodulation in AIDS
20. A prospective study of dietary intake and acquired immune deficiency syndrome in HIV-seropositive homosexual men
21. Potential therapeutics of vitamin E (tocopherol) in AIDS and HIV
22. Nutritional status and immune response in mice with murine AIDS are normalized by vitamin E supplementation
23. CD95's deadly mission in the immune system
24. Activation interferes with the APO-1 pathway in mature human T cells
25. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2
26. A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs
27. Real time quantitative PCR
28. T cell activation-induced and HIV Tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-κB
29. Vitamin E deficiency: Its effect on platelet-vascular interaction in various pathologic states
30. Intracellular oxidation/reduction status in the regulation of transcription factors NF-κB and AP-1
31. NF-κB as a primary regulator of the stress response
32. Vitamin E: A sensor and an information transducer of the cell oxidation state
33. Inhibition of NF-κB activation by vitamin E derivatives
34. Role of the Fas/Fas ligand apoptotic pathway in human immunodeficiency virus type 1 disease
35. Fas/Fas ligand on the road: An apoptotic pathway common to AIDS, autoimmunity, lymphoproliferation and transplantation
36. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein
37. Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children
38. Role of Fas ligand and receptor in the mechanism of T-cell depletion in AIDS: Effect on CD4+ lymphocyte depletion and HIV replication
39. Inhibition of cell proliferation by α-tocopherol. Role of protein kinase C
40. Protein kinase C-θ isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes
41. PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes
42. Integration of receptor-mediated signals in T cells by transmembrane adaptor proteins
43. The death of a T-cell: Expression of the CD95 ligand
44. Control of apoptosis by Rel/NF-κB transcription factors
45. Influence of HIV infection on vitamin status and requirements
46. Induction of apoptosis in mature T cells by tumour necrosis factor
47. Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis: Activation-induced death can occur without Fas receptor
48. Comparison of plasma cytokine levels in African patients with HIV-1 and HIV-2 infection
49. Raised levels of tumor necrosis factor-alpha and neopterin, but not interferon-alpha, in serum of HIV-1 infected patients from Ethiopia
50. Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection: TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection
51. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: Inhibition of Fas ligand expression by retinoic acid and glucocorticoids
52. 9-cis retinoic acid inhibition of activation-induced apoptosis is mediated via regulation of Fas ligand and requires retinoic acid receptor and retinoid X receptor activation
53. Retinoic acid inhibition of ex vivo human immunodeficiency virus-associated apoptosis of peripheral blood cells
54. Alteration of Fas/FasL expression of oral squamous cell carcinoma cell line Tca83 induced by retinoic acid
55. Retinoic acid inducing Fas expression in HL-60 cells
56. Selective upregulation of fibroblast Fas ligand expression, and prolongation of Fas/Fas ligand-mediated skin allograft survival, by retinoic acid: The skin as a retinoide-inducible immune privilege site
57. All-trans retinoic acid modulates Fas antigen expression and affects cell proliferation and apoptosis in combination with anti-Fas monoclonal antibody in the human myeloma cell line, U266B1
58. Regulation of CD95 (APO-1/Fas) ligand and receptor expression in human embryonal carcinoma cells by interferon gamma and all-trans retinoic acid